Biotech Buyout Binge Continues

For the second week in a row, buyout rumors and merger speculation sent a number of biotech and specialty pharmaceutical shares higher.


Comments are closed.

Do NOT follow this link or you will be banned from the site!
Get email updates

Get new actionable insights and updates from BiotechBlog